Akero Therapeutics Inc
AKRO
Market Cap$4.43B
Close$
$4.52
91.9% downside
Current Fair Value
91.9% downsideOvervalued by 91.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.43 Billion |
|---|---|
| Enterprise Value | $4.27 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.75 |
| Beta | -0.16 |
| Outstanding Shares | 78,656,629 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -16.24 |
|---|---|
| PEG | -49.83 |
| Price to Sales | - |
| Price to Book Ratio | 4.29 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -14.36 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data